IONIS PHARMACEUTICALS INC
IONSLatest QuantConomy context for IONS: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
IONIS PHARMACEUTICALS INC
QuantConomy has a structured record for IONS. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- IONS
- Name
- IONIS PHARMACEUTICALS INC
- Coverage
- 3 market/data records
- Sources
- alphavantage alpaca fmp sec nasdaq lse
Recent signals for IONS
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| corporate event reg fd disclosure | neutral | 70 | Jul 10, 10:20 AM | IONS filed 8-K: Regulation FD Disclosure - 1 material event - [strong neutral signal] |
| corporate event reg fd disclosure | neutral | 80 | Jul 9, 07:00 PM | IONS filed 8-K: Regulation FD Disclosure, Other Events - 2 material events - [very strong neutral signal] |
| proposed sale cluster proposed sale | very bearish | 28 | Jul 7, 08:40 PM | Cluster of 3 Form 144 filings for IONS - total $6.70M proposed sales - 10,111 shares - expected around 7/7/2026 - [very weak very bearish signal - supply pressure] |
PROPOSED_SALE signals are experimental: historical Form 144 coverage is still being backfilled, so results may be sparse or empty.
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| IONS | NASDAQ | alphavantage | Ionis Pharmaceuticals Inc |
| IONS | NASDAQ | alpaca | Ionis Pharmaceuticals, Inc. Common Stock |
| IONS | NASDAQ | fmp | Ionis Pharmaceuticals, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | BENNETT C FRANK | EVP, Chief Scientific Officer | sale | 5,536 | $83.58 | $462,693 | 4 on EDGAR |
| Jul 7, 2026 | Diaz Allene M. | Insider | exercise | 10,111 | $47.11 | $476,329 | 4 on EDGAR |
| Jul 7, 2026 | Kordasiewicz Holly B. | EVP, Chief Development Officer | sale | 362 | $84.30 | $30,517 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query IONS context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access